Lundbeck appeals against EU Commission fine
COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck has filed an appeal against a 93.8 million euros ($123.7 million) fine by the European Commission for deals with rivals to block the supply of generic versions of its citalopra anti-depressant to the market.
Lundbeck said in a statement that the aim of the appeal was to have the decision annulled or the fine reduced.
The company said it expects a decision on the appeal within two to three years.
($1 = 0.7584 euros)
(Reporting by Copenhagen Newsroom; Editing by David Goodman)
- U.S.'s Kerry expresses regret to India over diplomat case |
- Mega Millions winners in Georgia, California to split $648 million |
- China confirms near miss with U.S. ship in South China Sea
- Washington, DC city council raises minimum wage to $11.50/hr in 2016
- Fed cuts bond buying in first step away from historic stimulus |